| 04/09/2024 |
Suspension from Official Quotation |
| 02/09/2024 |
Pause in Trading |
| 02/09/2024 |
Trading Halt |
| 30/08/2024 |
F24 Appendix 4E and Preliminary Final Report |
| 30/08/2024 |
FY24 4E Presentation |
| 24/07/2024 |
AN1 – Company Update Licence Partnership Announcement |
| 24/07/2024 |
Appendix 4C Cash Flow & Activities Report |
| 28/06/2024 |
Confirmation of Release – AN1 – Lapse of unlisted options |
| 13/06/2024 |
Change of Company Secretary |
| 24/05/2024 |
Midkine Antibody Licensing Deal |
| 20/05/2024 |
Response to Appendix 3Y Query |
| 13/05/2024 |
Change of Director’s Interest Notices |
| 29/04/2024 |
Quarterly Activities_Appendix 4C Cash Flow Report |
| 19/04/2024 |
Change in substantial holding – HNG |
| 17/04/2024 |
Application for quotation of securities |
| 17/04/2024 |
Cleansing Notice |
| 17/04/2024 |
Notification regarding unquoted securities – AN1 |
| 11/04/2024 |
AN1 – Results of Meeting |
| 13/03/2024 |
Change of Director’s Interest Notice – Beard |
| 13/03/2024 |
Notice of General Meeting/Proxy Form |
| 11/03/2024 |
Change of Director’s Interest Notice – Beard |
| 08/03/2024 |
Organisational Changes |
| 27/02/2024 |
Appendix 4D and Half Year Report |
| 27/02/2024 |
H1 FY24 Results and Corporate Update |
| 20/02/2024 |
Change in substantial holding – HNG |
| 15/02/2024 |
Application for quotation of securities – AN1 |
| 15/02/2024 |
Cleansing Notice |
| 07/02/2024 |
Completion of Placement |
| 07/02/2024 |
Investor Presentation |
| 07/02/2024 |
Proposed issue of securities – AN1 |
| 07/02/2024 |
Proposed issue of securities – AN1 |
| 05/02/2024 |
Trading Halt |
| 31/01/2024 |
Quarterly Activities/Appendix 4C Cash Flow Report |
| 15/01/2024 |
Change in substantial holding |
